GC–MS and GC–MS/MS measurement of ibuprofen in 10-μL aliquots of human plasma and mice serum using [α-methylo-2H3]ibuprofen after ethyl acetate extraction and pentafluorobenzyl bromide derivatization: Discovery of a collision energy-dependent H/D isotope effect and pharmacokinetic application to inhaled ibuprofen-arginine in mice

Interpretation of negative-ion chemical ionization GC-MS and GC-MS/MS mass spectra of perfluorinated organic analyte derivatives: Consideration of reduction reactions in the gas phase

The main priniciples of gas chromatography-mass spectrometry (GC-MS) and gas chromatography-tandem mass spectrometry (GC-MS/MS) are: 1) separation of mostly derivatized analytes in the lumen of temperature-programmed gas chromatography (GC) fused-silica capillary columns, 2) ionization of gaseous charge-free analyte derivatives in the ion-source by means of electrons (electron ionization, EI) or in combination with a reagent gas such as methane (chemical ionization, CI), and 3) separation of simply ionized analytes or fragments in electric and/or magnetic fields due to their mass-to-charge ratio (m/z). EI generates (radical) cations, whereas CI is used to analyze either simply positively (positive-ion chemical ionization, PICI) or simply negatively charged analytes (negative-ion chemical ionization, NICI). In general, NICI in combination with the use of fluorinated (F) derivatization reagents is used in quantitative analyses as fluorinated analytes are softly ionized thus producing anions in high abundance and of high intensity. In quantitative analyses by GC-NICI-MS and GC-NICI-MS/MS, the position of the negative charge in the detected anions is secondary and in many cases unknown. The question of the position of the negative charge in analyte anions formed by NICI in GC-MS and GC-MS/MS is basically of theoretical interest and poorly addresed. The present article discusses this issue in detail. Previously reported GC-NICI-MS and GC-NICI-MS/MS quantitative methods for different classes of analytes, such as amino acids, fatty acids and drugs alongside their 2H-, 13C-, 15N- and 18O-isotopologs, after derivatization with fluorinated reagents including pentafluorobenzyl bromide (PFB-Br), pentafluorobenzoyl chloride (PFB-COCl) and pentafluoropropionic anhydride (PFPA) serve as examples and resources of data. ChemDraw Professional software was used to construct chemical structures of analytes and ions found in GC-NICI-MS and GC-NICI-MS/MS mass spectra. The results of the present study provide unique insights into the gas-phase reactions that take place in the ion-source of GC-MS and in the collision-chamber of GC-MS/MS instruments mainly based on the quadrupole (Q) technology. Paradoxically, the negative charge cannot be always assigned in precursor and product ions by standard rules of chemistry, unlike in EI and PICI. For example, PFB esters of fatty acids and eicosanoids (R-COO-PFB) ionize to form their carboxylates with the negative charge being definetly located in the carboxylic groups (R-COO-, [M-PFB]-). In contrast, methyl ester pentafluoropropionyl derivatives of amino acids ionize readily and abundantly under NICI conditions, yet the negative charge cannot be always asigned with apodictic certainty, even not for the calibrating/tuning compound perfluorotributylamine (PFTBA). The paradox vanishes when considering gas-phase reactions in the ion-source as reduction reactions of secondary electrons with analytes molecules. The present work should be helpful guide in intepreting GC-NICI-MS and GC-NICI-MS/MS mass spectra of derivatized analytes and their isotopologs, as well as in developing analyte-specific quantitative methods for endogenous and exogenous substances including drugs in biological samples.

Underlying Mechanisms of Chromatographic H/D, H/F, cis/trans and Isomerism Effects in GC-MS

Charge-free gaseous molecules labeled with deuterium 2H (D) atoms elute earlier than their protium-analogs 1H (H) from most stationary GC phases. This effect is known as the chromatographic H/D isotope effect (hdIEC) and can be calculated by dividing the retention times (tR) of the protiated (tR(H) ) to those of the deuterated (tR(D)) analytes: hdIEC = tR(H)/tR(D). Analytes labeled with 13C, 15N or 18O have almost identical retention times and lack a chromatographic isotope effect. Derivatives of cis- and trans-analytes such as cis- and trans-fatty acids also differ in their retention times. Analytes that contain trans-C=C-double bonds elute earlier in gas chromatography-mass spectrometry (GC-MS) than their cis-C=C-double bonds containing congeners. The chromatographic cis/trans-effect (ctEC) can be calculated by dividing the retention times of the cis- by those of the trans-analytes: ctEC = tR(c)/tR(t). In the present work, the hdIEC and ctEC values of endogenous and exogenous substances were calculated from previously reported GC-MS analyses and found to range each between 1.0009 and 1.0400. The examination suggests that the H/D-isotope effects and the cis/trans-effects observed in GC-MS are based on differences in the inter-molecular interaction strengths of the analyte derivatives with the stationary phase of GC columns. The deuterium atoms, being larger than the H atoms of the analytes, attenuate the interaction of the skeleton of the molecules with the GC stationary phase. The angulation of trans-analytes decreases the interaction of the skeleton of the molecules with the GC stationary phase, as only parts of the molecules are close enough to the GC stationary phase to interact. Other chromatographic effects caused by hydrogen (H) and fluorine (F) atoms and by stereo-isomerism are considered to be based on a similar mechanism due to the different orientation of the side chains.

Enantioselective separation and determination of ibuprofen: Stereoselective pharmacokinetics, pharmacodynamics and analytical methods

Ibuprofen (IBP), the 29th most prescribed drug in the United States in 2019, is a widely used nonsteroidal anti-inflammatory drug (NSAID) comprising two enantiomers, (R)-IBP and (S)-IBP, collectively known as (RS)-IBP. This critical review examines analytical techniques for the enantioselective separation and determination of IBP enantiomers, crucial for pharmaceutical and clinical applications. The review focuses on state-of-the-art methods, including chromatographic techniques including high-performance liquid chromatography, gas chromatography, liquid chromatography-tandem mass spectrometry, and some other techniques. This review addresses pharmacokinetics, pharmacology, and side effects of each enantiomer, ensuring safe drug usage. By consolidating diverse analytical methods and their applicability in different matrices, this review serves as a valuable resource for researchers, analysts, and practitioners in pharmaceutical analysis, pharmacology, and clinical studies.

Unusual Derivatization of Methylmalonic Acid with Pentafluorobenzyl Bromide to a Tripentafluorobenzyl Derivative and Its Stable-Isotope Dilution GC-MS Measurement in Human Urine

Methylmalonic acid (MMA) is a very short dicarboxylic acid (methylpropanedioic acid; CH₃CH(COOH)₂; pK_a1, 3.07; pK_a2, 5.76) associated with vitamin B₁₂ deficiency and many other patho-physiological conditions. In this work, we investigated several carboxylic groups-specific derivatization reactions and tested their utility for the quantitative analysis of MMA in human urine and plasma by gas chromatography-mass spectrometry (GC-MS). The most useful derivatization procedure was the reaction of unlabeled MMA (d₀-MMA) and trideutero-methyl malonic acid (d₃-MMA) with 2,3,4,5,6-pentafluorobenzyl bromide (PFB-Br) in acetone. By heating at 80 °C for 60 min, we observed the formation of the dipentafluorobenzyl (PFB) ester of MMA (CH₃CH(COOPFB)₂). In the presence of N,N-diisopropylamine, heating at 80 °C for 60 min resulted in the formation of a tripentafluorobenzyl derivative of MMA, i.e., CH₃CPFB(COOPFB)₂). The retention time was 5.6 min for CH₃CH(COOPFB)₂ and 7.3 min for CH₃CPFB(COOPFB)₂). The most intense ions in the negative-ion chemical ionization (NICI) GC-MS spectra of CH₃CH(COOPFB)₂ were mass-to-charge (m/z) 233 for d₀-MMA and m/z 236 for d₃-MMA. The most intense ions in the NICI GC-MS spectra of CH₃CPFB(COOPFB)₂ were mass-to-charge (m/z) 349 for d₀-MMA and m/z 352 for d₃-MMA. These results indicate that the H at C atom at position 2 is C-H acidic and is alkylated by PFB-Br only in the presence of the base N,N-diisopropylamine. Method validation and quantitative analyses in human urine and plasma were performed by selected ion monitoring (SIM) of m/z 349 for d₀-MMA and m/z 352 for the internal standard d₃-MMA in the NICI mode. We used the method to measure the urinary excretion rates of MMA in healthy black (n = 39) and white (n = 41) boys of the Arterial Stiffness in Offspring Study (ASOS). The creatinine-corrected excretion rates of MMA were 1.50 [0.85–2.52] µmol/mmol in the black boys and 1.34 [1.02–2.18] µmol/mmol in the white boys (P = 0.85; Mann–Whitney). The derivatization procedure is highly specific and sensitive for MMA and allows its accurate and precise measurement in 10-µl of human urine by GC-MS.

API Content and Blend Uniformity Using Quantum Cascade Laser Spectroscopy Coupled with Multivariate Analysis

The process analytical technology (PAT) initiative proposed by the US Food and Drug Administration (FDA) suggests innovative methods to better understand pharmaceutical processes. The development of analytical methods that quantify active pharmaceutical ingredients (APIs) in powders and tablets is fundamental to monitoring and controlling a drug product's quality. Analytical methods based on vibrational spectroscopy do not require sample preparation and can be implemented during in-line manufacturing to maintain quality at each stage of operations. In this study, a mid-infrared (MIR) quantum cascade laser (QCL) spectroscopy-based protocol was performed to quantify ibuprofen in formulations of powder blends and tablets. Fourteen blends were prepared with varying concentrations from 0.0% to 21.0% (w/w) API. MIR laser spectra were collected in the spectral range of 990 to 1600 cm^-1. Partial least squares (PLS) models were developed to correlate the intensities of vibrational signals with API concentrations in powder blends and tablets. PLS models were evaluated based on the following figures of merit: correlation coefficient (R²), root mean square error of calibration, root mean square error of prediction, root mean square error of cross-validation, and relative standard error of prediction. QCL assisted by multivariate analysis was demonstrated to be accurate and robust for analysis of the content and blend uniformity of pharmaceutical compounds.

Application of Molecularly Imprinted Polymers (MIP) and Flowing Atmospheric-Pressure Afterglow Mass Spectrometry (FAPA-MS) to Analysis of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

In recent years, the rapid development of the pharmaceutical industry and the extensive and illicit use of painkillers have led to increased levels of nonsteroidal anti-inflammatory drugs (NSAIDs) in the environment. In view of the significant impact of NSAIDs on living organisms, including humans, their presence in the environment needs to be continuously monitored at trace levels. For this purpose, a combination of molecularly imprinted solid-phase extraction (MISPE) and HPLC-MS analysis is commonly used. MISPE has been utilized in direct, fast, and ecological analysis of drugs using a flowing atmospheric-pressure afterglow ion source for mass spectrometry (FAPA-MS). The new method was applied herein in the determination of naproxen, diclofenac, and ibuprofen. The linear dependence of the intensity of analytical signals on the amount of drugs is in the range of 0.2 μg to 1 g and the method detection limit (MDL) for all drugs is 0.2 μg in environmental samples. The new method also decreased the number of analytical stages, the time and cost of analysis, and the organic solvent consumption, besides being environmentally friendly.

GC-NICI-MS analysis of acetazolamide and other sulfonamide (R-SO2-NH2) drugs as pentafluorobenzyl derivatives [R-SO2-N(PFB)2] and quantification of pharmacological acetazolamide in human urine

Acetazolamide (molecular mass (MM), 222) belongs to the class of sulfonamides (R-SO₂-NH₂) and is one of the strongest pharmacological inhibitors of carbonic anhydrase activity. Acetazolamide is excreted unchanged in the urine. Here, we report on the development, validation and biomedical application of a stable-isotope dilution GC-MS method for the reliable quantitative determination of acetazolamide in human urine. The method is based on evaporation to dryness of 50 μL urine aliquots, base-catalyzed derivatization of acetazolamide (d₀-AZM) and its internal standard [acetylo-²H₃]acetazolamide (d₃-AZM) in 30 vol% pentafluorobenzyl (PFB) bromide in acetonitrile (60 min, 30 °C), reconstitution in toluene (200 μL) and injection of 1-μL aliquots. The negative-ion chemical ionization (NICI) mass spectra (methane) of the PFB derivatives contained several intense ions including [M]^‒ at m/z 581 for d₀-AZM and m/z 584 for d₃-AZM, suggesting derivatization of their sulfonamide groups to form N,N-dipentafluorobenzyl derivatives (R-SO₂-N(PFB)₂), i.e., d₀-AZM-(PFB)₂ and d₃-AZM-(PFB)₂, respectively. Quantification was performed by selected-ion monitoring of m/z 581 and 83 for d₀-AZM-(PFB)₂ and m/z 584 and 86 for d₃-AZM-(PFB)₂. The limits of detection and quantitation of the method were determined to be 300 fmol (67 pg) and 1 μM of acetazolamide, respectively. Intra- and inter-assay precision and accuracy for acetazolamide in human urine samples in pharmacologically relevant concentration ranges were determined to be 0.3%–4.2% and 95.3%–109%, respectively. The method was applied to measure urinary acetazolamide excretion after ingestion of a 250 mg acetazolamide-containing tablet (Acemit®) by a healthy volunteer. Among other tested sulfonamide drugs, methazolamide (MM, 236) was also found to form a N,N-dipentafluorobenzyl derivative, whereas dorzolamide (MM, 324) was hardly detectable. No GC-MS peaks were obtained from the PFB bromide derivatization of hydrochlorothiazide (MM, 298), xipamide (MM, 355), indapamide and metholazone (MM, 366 each) or brinzolamide (MM, 384). We demonstrate for the first time that sulfonamide drugs can be derivatized with PFB bromide and quantitated by GC-MS. Sulfonamides with MM larger than 236 are likely to be derivatized by PFB bromide but to lack thermal stability.

•

The sulfonamide group of acetazolamide was derivatized for the first time with pentafluorobenzyl bromide.

•

Other sulfonamides were also derivatized for the first time with pentafluorobenzyl bromide.

•

Pentafluorobenzyl derivatives of acetazolamide and other sulfonamides are useful for GC-MS.

•

The validated method was used to quantify pharmacological acetazolamide in human urine.